![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 18443 |
FusionGeneSummary for KDM4A_OPRD1 |
![]() |
Fusion gene information | Fusion gene name: KDM4A_OPRD1 | Fusion gene ID: 18443 | Hgene | Tgene | Gene symbol | KDM4A | OPRD1 | Gene ID | 9682 | 4985 |
Gene name | lysine demethylase 4A | opioid receptor delta 1 | |
Synonyms | JHDM3A|JMJD2|JMJD2A|TDRD14A | OPRD | |
Cytomap | 1p34.2-p34.1 | 1p35.3 | |
Type of gene | protein-coding | protein-coding | |
Description | lysine-specific demethylase 4AjmjC domain-containing histone demethylation protein 3Ajumonji C domain-containing histone demethylase 3Ajumonji domain containing 2jumonji domain containing 2Ajumonji domain-containing protein 2Alysine (K)-specific dem | delta-type opioid receptorD-OR-1DOR-1delta opioid receptor 1 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | O75164 | P41143 | |
Ensembl transtripts involved in fusion gene | ENST00000372396, ENST00000463151, | ENST00000234961, | |
Fusion gene scores | * DoF score | 13 X 12 X 9=1404 | 1 X 1 X 1=1 |
# samples | 13 | 1 | |
** MAII score | log2(13/1404*10)=-3.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
Context | PubMed: KDM4A [Title/Abstract] AND OPRD1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | KDM4A | GO:0016577 | histone demethylation | 16024779 |
Hgene | KDM4A | GO:0045892 | negative regulation of transcription, DNA-templated | 16024779 |
Hgene | KDM4A | GO:0070544 | histone H3-K36 demethylation | 21914792 |
Tgene | OPRD1 | GO:0000060 | protein import into nucleus, translocation | 16325578 |
Tgene | OPRD1 | GO:0007186 | G-protein coupled receptor signaling pathway | 16325578 |
Tgene | OPRD1 | GO:0010629 | negative regulation of gene expression | 24613828 |
Tgene | OPRD1 | GO:0032460 | negative regulation of protein oligomerization | 24613828 |
Tgene | OPRD1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 24613828 |
Tgene | OPRD1 | GO:0051881 | regulation of mitochondrial membrane potential | 24613828 |
Tgene | OPRD1 | GO:0071456 | cellular response to hypoxia | 24613828 |
Tgene | OPRD1 | GO:0097237 | cellular response to toxic substance | 24613828 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | CHOL | TCGA-W5-AA36-01A | KDM4A | chr1 | 44121437 | + | OPRD1 | chr1 | 29185466 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000372396 | ENST00000234961 | KDM4A | chr1 | 44121437 | + | OPRD1 | chr1 | 29185466 | + |
3UTR-3CDS | ENST00000463151 | ENST00000234961 | KDM4A | chr1 | 44121437 | + | OPRD1 | chr1 | 29185466 | + |
Top |
FusionProtFeatures for KDM4A_OPRD1 |
![]() |
Hgene | Tgene |
KDM4A | OPRD1 |
Histone demethylase that specifically demethylates 'Lys-9' and 'Lys-36' residues of histone H3, thereby playing a centralrole in histone code (PubMed:26741168). Does not demethylatehistone H3 'Lys-4', H3 'Lys-27' nor H4 'Lys-20'. Demethylatestrimethylated H3 'Lys-9' and H3 'Lys-36' residue, while it has noactivity on mono- and dimethylated residues. Demethylation of Lysresidue generates formaldehyde and succinate. Participates intranscriptional repression of ASCL2 and E2F-responsive promotersvia the recruitment of histone deacetylases and NCOR1,respectively. {ECO:0000269|PubMed:16024779,ECO:0000269|PubMed:16603238, ECO:0000269|PubMed:26741168}. Isoform 2: Crucial for muscle differentiation, promotestranscriptional activation of the Myog gene by directing theremoval of repressive chromatin marks at its promoter. Lacks theN-terminal demethylase domain. {ECO:0000269|PubMed:21694756}. | G-protein coupled receptor that functions as receptorfor endogenous enkephalins and for a subset of other opioids.Ligand binding causes a conformation change that triggerssignaling via guanine nucleotide-binding proteins (G proteins) andmodulates the activity of down-stream effectors, such as adenylatecyclase. Signaling leads to the inhibition of adenylate cyclaseactivity. Inhibits neurotransmitter release by reducing calciumion currents and increasing potassium ion conductance. Plays arole in the perception of pain and in opiate-mediated analgesia.Plays a role in developing analgesic tolerance to morphine.{ECO:0000269|PubMed:22184124, ECO:0000269|PubMed:7808419,ECO:0000269|PubMed:8201839}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | KDM4A | chr1:44121437 | chr1:29185466 | ENST00000372396 | + | 3 | 22 | 14_56 | 104 | 1065 | Domain | JmjN |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 111_122 | 75 | 373 | Topological domain | Extracellular |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 145_163 | 75 | 373 | Topological domain | Cytoplasmic |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 187_206 | 75 | 373 | Topological domain | Extracellular |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 239_261 | 75 | 373 | Topological domain | Cytoplasmic |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 285_299 | 75 | 373 | Topological domain | Extracellular |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 322_372 | 75 | 373 | Topological domain | Cytoplasmic |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 76_85 | 75 | 373 | Topological domain | Cytoplasmic |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 123_144 | 75 | 373 | Transmembrane | Helical%3B Name%3D3 |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 164_186 | 75 | 373 | Transmembrane | Helical%3B Name%3D4 |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 207_238 | 75 | 373 | Transmembrane | Helical%3B Name%3D5 |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 262_284 | 75 | 373 | Transmembrane | Helical%3B Name%3D6 |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 300_321 | 75 | 373 | Transmembrane | Helical%3B Name%3D7 |
Tgene | >OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 86_110 | 75 | 373 | Transmembrane | Helical%3B Name%3D2 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >KDM4A | chr1:44121437 | chr1:29185466 | ENST00000372396 | + | 3 | 22 | 142_308 | 104 | 1065 | Domain | JmjC |
Hgene | >KDM4A | chr1:44121437 | chr1:29185466 | ENST00000372396 | + | 3 | 22 | 897_954 | 104 | 1065 | Domain | Note=Tudor 1 |
Hgene | >KDM4A | chr1:44121437 | chr1:29185466 | ENST00000372396 | + | 3 | 22 | 955_1011 | 104 | 1065 | Domain | Note=Tudor 2 |
Hgene | >KDM4A | chr1:44121437 | chr1:29185466 | ENST00000372396 | + | 3 | 22 | 709_767 | 104 | 1065 | Zinc finger | Note=PHD-type 1 |
Hgene | >KDM4A | chr1:44121437 | chr1:29185466 | ENST00000372396 | + | 3 | 22 | 772_805 | 104 | 1065 | Zinc finger | C2HC pre-PHD-type |
Hgene | >KDM4A | chr1:44121437 | chr1:29185466 | ENST00000372396 | + | 3 | 22 | 828_885 | 104 | 1065 | Zinc finger | PHD-type 2 |
Tgene | OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 1_47 | 75 | 373 | Topological domain | Extracellular |
Tgene | OPRD1 | chr1:44121437 | chr1:29185466 | ENST00000234961 | + | 0 | 3 | 48_75 | 75 | 373 | Transmembrane | Helical%3B Name%3D1 |
Top |
FusionGeneSequence for KDM4A_OPRD1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_KDM4A_ENST00000372396_chr1_44121437_+_OPRD1_ENST00000234961_chr1_29185466_+_402aa MASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKK AMTVREFRKIANSDKYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVC HPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLR SVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQ |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_KDM4A_ENST00000372396_chr1_44121437_+_OPRD1_ENST00000234961_chr1_29185466_+_1206nt ATGGCTTCTGAGTCTGAAACTCTGAATCCCAGTGCTAGGATAATGACCTTTTATCCAACTATGGAAGAGTTCCGAAACTTCAGTAGATAC ATTGCCTACATTGAATCCCAAGGAGCTCATCGGGCAGGGCTAGCCAAGGTTGTTCCTCCAAAAGAGTGGAAGCCACGAGCATCCTATGAT GACATTGATGATTTGGTCATTCCTGCCCCCATTCAACAGCTGGTGACGGGGCAGTCTGGCCTCTTTACTCAGTACAACATACAGAAGAAA GCCATGACTGTTCGAGAGTTCCGCAAGATAGCCAATAGCGATAAGTACACTAAGATGAAGACGGCCACCAACATCTACATCTTCAACCTG GCCTTAGCCGATGCGCTGGCCACCAGCACGCTGCCTTTCCAGAGTGCCAAGTACCTGATGGAGACGTGGCCCTTCGGCGAGCTGCTCTGC AAGGCTGTGCTCTCCATCGACTACTACAATATGTTCACCAGCATCTTCACGCTCACCATGATGAGTGTTGACCGCTACATCGCTGTCTGC CACCCTGTCAAGGCCCTGGACTTCCGCACGCCTGCCAAGGCCAAGCTGATCAACATCTGTATCTGGGTCCTGGCCTCAGGCGTTGGCGTG CCCATCATGGTCATGGCTGTGACCCGTCCCCGGGACGGGGCAGTGGTGTGCATGCTCCAGTTCCCCAGCCCCAGCTGGTACTGGGACACG GTGACCAAGATCTGCGTGTTCCTCTTCGCCTTCGTGGTGCCCATCCTCATCATCACCGTGTGCTATGGCCTCATGCTGCTGCGCCTGCGC AGTGTGCGCCTGCTGTCGGGCTCCAAGGAGAAGGACCGCAGCCTGCGGCGCATCACGCGCATGGTGCTGGTGGTTGTGGGCGCCTTCGTG GTGTGTTGGGCGCCCATCCACATCTTCGTCATCGTCTGGACGCTGGTGGACATCGACCGGCGCGACCCGCTGGTGGTGGCTGCGCTGCAC CTGTGCATCGCGCTGGGCTACGCCAATAGCAGCCTCAACCCCGTGCTCTACGCTTTCCTCGACGAGAACTTCAAGCGCTGCTTCCGCCAG CTCTGCCGCAAGCCCTGCGGCCGCCCAGACCCCAGCAGCTTCAGCCGCGCCCGCGAAGCCACGGCCCGCGAGCGTGTCACCGCCTGCACC |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_KDM4A_ENST00000372396_chr1_44121437_+_OPRD1_ENST00000234961_chr1_29185466_+_1753nt GGAGTTTCGGCCTTCGCCTGCTGGAAAAGCAGTAGGATCGGCCAGTGGCGACAGCAGGAGCTGAGCCTAAGCCCTGGCGGGGCTTTGGGC TGTAGATTCCTGTCTGACTAAAGGGACCTCAAAAAGGAGGGAAAATGGCTTCTGAGTCTGAAACTCTGAATCCCAGTGCTAGGATAATGA CCTTTTATCCAACTATGGAAGAGTTCCGAAACTTCAGTAGATACATTGCCTACATTGAATCCCAAGGAGCTCATCGGGCAGGGCTAGCCA AGGTTGTTCCTCCAAAAGAGTGGAAGCCACGAGCATCCTATGATGACATTGATGATTTGGTCATTCCTGCCCCCATTCAACAGCTGGTGA CGGGGCAGTCTGGCCTCTTTACTCAGTACAACATACAGAAGAAAGCCATGACTGTTCGAGAGTTCCGCAAGATAGCCAATAGCGATAAGT ACACTAAGATGAAGACGGCCACCAACATCTACATCTTCAACCTGGCCTTAGCCGATGCGCTGGCCACCAGCACGCTGCCTTTCCAGAGTG CCAAGTACCTGATGGAGACGTGGCCCTTCGGCGAGCTGCTCTGCAAGGCTGTGCTCTCCATCGACTACTACAATATGTTCACCAGCATCT TCACGCTCACCATGATGAGTGTTGACCGCTACATCGCTGTCTGCCACCCTGTCAAGGCCCTGGACTTCCGCACGCCTGCCAAGGCCAAGC TGATCAACATCTGTATCTGGGTCCTGGCCTCAGGCGTTGGCGTGCCCATCATGGTCATGGCTGTGACCCGTCCCCGGGACGGGGCAGTGG TGTGCATGCTCCAGTTCCCCAGCCCCAGCTGGTACTGGGACACGGTGACCAAGATCTGCGTGTTCCTCTTCGCCTTCGTGGTGCCCATCC TCATCATCACCGTGTGCTATGGCCTCATGCTGCTGCGCCTGCGCAGTGTGCGCCTGCTGTCGGGCTCCAAGGAGAAGGACCGCAGCCTGC GGCGCATCACGCGCATGGTGCTGGTGGTTGTGGGCGCCTTCGTGGTGTGTTGGGCGCCCATCCACATCTTCGTCATCGTCTGGACGCTGG TGGACATCGACCGGCGCGACCCGCTGGTGGTGGCTGCGCTGCACCTGTGCATCGCGCTGGGCTACGCCAATAGCAGCCTCAACCCCGTGC TCTACGCTTTCCTCGACGAGAACTTCAAGCGCTGCTTCCGCCAGCTCTGCCGCAAGCCCTGCGGCCGCCCAGACCCCAGCAGCTTCAGCC GCGCCCGCGAAGCCACGGCCCGCGAGCGTGTCACCGCCTGCACCCCGTCCGATGGTCCCGGCGGTGGCGCTGCCGCCTGACCAGGCCATC CGGCCCCCAGAGCGCCCCTCCCTAGTGACCCGGAGGCCACATGAGTCCCAGTGGGAGGCGCGAGCCATGATGTGGAGTGGGGCAGTAGAA GGTCGGAGGCTTGGGACCGCCAGATGGGGCCTCTGTTTCGGAGACGGGACCGGGCCGCTAGATGGGCATGGGGTGGGCCTCTGGTTTGGG GCGAGGCAGAGGACAGATCAATGGCGCAGTGCCTCTGGTCTGGGTGCCCCGTCCACGGCTCTAGGTGGGGCGGGAAAGCCAGTGACTCCA GGAGAGGAGCGGGACCTGTGGCTCTACAACTGAGTCCTTAAACAGGGCATCTCCAGGAAGGCGGGGCTTCAACCTTGAGACAGCTTCGGT |
Top |
FusionGenePPI for KDM4A_OPRD1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
KDM4A | NCOR1, WDR48, KDM4A, KDM4C, HIST1H3A, HDAC1, HDAC3, RB1, AR, WAS, HIST1H4A, RNF8, RNF168, H3F3A, CUL1, FBXL4, MOV10, NXF1, CAPZA1, EPHB2, ZNF131, ZNF414, CCL22, STK11, KDM4B, ABHD5 | OPRD1 | GPRASP1, OPRD1, ADRB2, ARRB1, ARRB2, OPRM1, GNAO1, CANX, HSPA4, SEC61A1, AUP1, GJA4, DOK4, SIAH1, SIAH2, VAPA, WLS |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | KDM4A | chr1:44121437 | chr1:29185466 | ENST00000372396 | + | 3 | 22 | 597_638 | 104 | 1065 | NCOR1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for KDM4A_OPRD1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | OPRD1 | P41143 | DB00321 | Amitriptyline | Delta-type opioid receptor | small molecule | approved |
Tgene | OPRD1 | P41143 | DB00333 | Methadone | Delta-type opioid receptor | small molecule | approved |
Tgene | OPRD1 | P41143 | DB00514 | Dextromethorphan | Delta-type opioid receptor | small molecule | approved |
Tgene | OPRD1 | P41143 | DB00836 | Loperamide | Delta-type opioid receptor | small molecule | approved |
Tgene | OPRD1 | P41143 | DB00844 | Nalbuphine | Delta-type opioid receptor | small molecule | approved |
Tgene | OPRD1 | P41143 | DB00899 | Remifentanil | Delta-type opioid receptor | small molecule | approved |
Tgene | OPRD1 | P41143 | DB06204 | Tapentadol | Delta-type opioid receptor | small molecule | approved |
Tgene | OPRD1 | P41143 | DB00318 | Codeine | Delta-type opioid receptor | small molecule | approved|illicit |
Tgene | OPRD1 | P41143 | DB00327 | Hydromorphone | Delta-type opioid receptor | small molecule | approved|illicit |
Tgene | OPRD1 | P41143 | DB00956 | Hydrocodone | Delta-type opioid receptor | small molecule | approved|illicit |
Tgene | OPRD1 | P41143 | DB01081 | Diphenoxylate | Delta-type opioid receptor | small molecule | approved|illicit |
Tgene | OPRD1 | P41143 | DB09209 | Pholcodine | Delta-type opioid receptor | small molecule | approved|illicit |
Tgene | OPRD1 | P41143 | DB11130 | Opium | Delta-type opioid receptor | small molecule | approved|illicit |
Tgene | OPRD1 | P41143 | DB00497 | Oxycodone | Delta-type opioid receptor | small molecule | approved|illicit|investigational |
Tgene | OPRD1 | P41143 | DB01452 | Heroin | Delta-type opioid receptor | small molecule | approved|illicit|investigational |
Tgene | OPRD1 | P41143 | DB00813 | Fentanyl | Delta-type opioid receptor | small molecule | approved|illicit|investigational|vet_approved |
Tgene | OPRD1 | P41143 | DB00921 | Buprenorphine | Delta-type opioid receptor | small molecule | approved|illicit|investigational|vet_approved |
Tgene | OPRD1 | P41143 | DB00647 | Dextropropoxyphene | Delta-type opioid receptor | small molecule | approved|illicit|investigational|withdrawn |
Tgene | OPRD1 | P41143 | DB00611 | Butorphanol | Delta-type opioid receptor | small molecule | approved|illicit|vet_approved |
Tgene | OPRD1 | P41143 | DB00193 | Tramadol | Delta-type opioid receptor | small molecule | approved|investigational |
Tgene | OPRD1 | P41143 | DB00295 | Morphine | Delta-type opioid receptor | small molecule | approved|investigational |
Tgene | OPRD1 | P41143 | DB00708 | Sufentanil | Delta-type opioid receptor | small molecule | approved|investigational |
Tgene | OPRD1 | P41143 | DB06274 | Alvimopan | Delta-type opioid receptor | small molecule | approved|investigational |
Tgene | OPRD1 | P41143 | DB06738 | Ketobemidone | Delta-type opioid receptor | small molecule | approved|investigational |
Tgene | OPRD1 | P41143 | DB00704 | Naltrexone | Delta-type opioid receptor | small molecule | approved|investigational|vet_approved |
Tgene | OPRD1 | P41143 | DB06230 | Nalmefene | Delta-type opioid receptor | small molecule | approved|investigational|withdrawn |
Tgene | OPRD1 | P41143 | DB01183 | Naloxone | Delta-type opioid receptor | small molecule | approved|vet_approved |
Tgene | OPRD1 | P41143 | DB01221 | Ketamine | Delta-type opioid receptor | small molecule | approved|vet_approved |
Top |
RelatedDiseases for KDM4A_OPRD1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | OPRD1 | C0001973 | Alcoholic Intoxication, Chronic | 4 | PSYGENET |
Tgene | OPRD1 | C0236969 | Substance-Related Disorders | 2 | CTD_human |
Tgene | OPRD1 | C0600427 | Cocaine Dependence | 2 | PSYGENET |
Tgene | OPRD1 | C0014544 | Epilepsy | 1 | CTD_human |
Tgene | OPRD1 | C0020651 | Hypotension, Orthostatic | 1 | CTD_human |
Tgene | OPRD1 | C0033975 | Psychotic Disorders | 1 | PSYGENET |
Tgene | OPRD1 | C0038587 | Substance Withdrawal Syndrome | 1 | CTD_human |
Tgene | OPRD1 | C0349204 | Nonorganic psychosis | 1 | PSYGENET |